// App-Quantinova.ai

: Transplantation of NAT+HCV Donor Lungs into Non-Infected Recipients Followed by Treatment with Sofosbuvir/Velpatasvir (S/V)

Researchers

Presenter

  • M. Cypel

Principal Investigators

  • J. Feld

  • L.G. Singer

  • N. Marks

  • I. Bahinskaya

  • M. Kuczynski

  • D. Kumar

  • M. Galasso

  • R. Ribeiro

  • J. Yeung

  • L. Donahoe

  • A. Pierre

  • M. de Perrot

  • K. Yasufuku

  • T.K. Waddell

  • S. Keshavjee

  • A. Humar

Medical Centers

  • Toronto Western Hospital, Toronto, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Velpatasvir/sofosbuvir

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • NCT03112044

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved